- ByInvesting.com-
Tuesday - KeyBanc Capital Markets has initiated coverage on GitLab Inc (NASDAQ:GTLB), assigning an Overweight rating with a price target of $70.00 for the shares. The firm's...
Last | Chg. | ||||
---|---|---|---|---|---|
0.3419 | +0.1519 | +79.95% | 2.26M | ||
1.57 | +0.39 | +33.05% | 1.17M | ||
1.33 | +0.25 | +23.15% | 949.65K | ||
0.437 | +0.0770 | +21.39% | 522.21K | ||
8.42 | +0.18 | +2.18% | 227.23K | ||
3.29 | +0.390 | +13.45% | 197.84K | ||
173.60 | -0.20 | -0.12% | 154.61K | ||
5.49 | -0.05 | -0.90% | 142.5K | ||
0.149 | +0.0022 | +1.50% | 99.23K | ||
0.172 | -0.201000 | -53.89% | 84K |
Name | Last | Chg. % | Vol. |
---|---|---|---|
20.71 | +94.64% | 81.56K | |
0.3419 | +79.95% | 2.26M | |
1.57 | +33.05% | 1.17M | |
3.00 | +23.97% | 0.01K | |
1.33 | +23.15% | 949.65K | |
0.437 | +21.39% | 522.21K | |
1.25 | +20.19% | 0.47K | |
5.07 | +20.14% | 16.68K | |
0.02 | +18.00% | 3.48K | |
1.59 | +16.06% | 0.02K |
Name | Last | Chg. % | Vol. |
---|---|---|---|
0.172 | -53.89% | 84K | |
5.50 | -19.12% | 22.99K | |
0.612 | -17.57% | 3.96K | |
1.85 | -17.41% | 0.45K | |
0.1562 | -14.64% | 65.28K | |
1.12 | -13.85% | 0.7K | |
0.22 | -13.73% | 25.67K | |
0.50 | -13.19% | 4.44K | |
15.98 | -12.10% | 2.58K | |
15.62 | -10.59% | 3.46K |
Time | Cur. | Imp. | Event | Actual | Forecast | Previous |
---|---|---|---|---|---|---|
Tuesday, March 19, 2024 | ||||||
20:30 | USD | 1.50M | 1.489M | |||
20:30 | USD | -0.30% | ||||
20:30 | USD | -14.80% | ||||
20:30 | USD | 1.43M | 1.331M | |||
20:55 | USD | 3.00% | ||||
23:30 | USD | 4.695% | ||||
Wednesday, March 20, 2024 | ||||||
00:30 | USD | 2.30% | 2.30% |
Tuesday - KeyBanc Capital Markets has initiated coverage on GitLab Inc (NASDAQ:GTLB), assigning an Overweight rating with a price target of $70.00 for the shares. The firm's...
On Tuesday, KeyBanc initiated coverage on Atlassian (NASDAQ:TEAM) Corporation stock (NASDAQ:TEAM), assigning a Sector Weight rating. The firm highlighted Atlassian's strong...
TEANECK, N.J. - Cognizant Technology Solutions Corp. (NASDAQ:CTSH) has announced a collaboration with NVIDIA Corporation (NASDAQ:NVDA) to enhance drug discovery in the life...
Tuesday, Baird initiated coverage on shares of Axsome Therapeutics (NASDAQ:AXSM), assigning the stock an Outperform rating and setting a price target of $108.00. The firm has...
On Tuesday, Baird initiated coverage on Alkermes stock (NASDAQ:ALKS), a biopharmaceutical company, with an Outperform rating and a price target of $37.00. The firm's analyst cited...
The Russell 2000 (IWM) has been defending its 50-day MA over the early part of 2024, but the last few days have seen a shift in this support with 'sell' triggers in the MACD and...
If you had been following the S&P 500 closely this past week, it likely would have left you scratching your head if you were trying to align the news with the market action. For...
Amid upcoming central bank meetings and crucial macroeconomic data releases, market sentiment is poised for potential shifts. While broader market indexes may continue to...
Last week we wrote about how M&A activity has been light so far for 2024, well the same holds for IPO activity. However, next week brings two highly anticipated public debuts that...
This year, the S&P 500 has seen a remarkable streak of 17 new all-time highs, outpacing many previous years. Notably, Warren Buffett's Berkshire Hathaway has stakes in two...